High-risk patients with left ventricular dysfunction fare as well, or better, without the support of a microaxial flow pump ...

ATLANTA -- Routine use of the Impella CP microaxial flow pump significantly improved survival in patients with infarct-related cardiogenic shock, the randomized DanGer Shock trial showed. In more than ...

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't ...

Study investigators cautioned against routine use of the device in complex percutaneous coronary interventions and to treat ...

Randomized trials neutral for pump device in complex elective cases, STEMI with reperfusio ...

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage. That is ...

BOSTON, MA, UNITED STATES, March 4, 2026 /EINPresswire.com/ — UltraSight™, a leader in AI-guided cardiac imaging workflows, today announced Late-Breaking clinical ...

PVAD IQ is UltraSight’s FDA-cleared AI-powered software designed to assist healthcare providers in managing patients who use microaxial flow pumps, a type of trans-aortic percutaneous ventricular ...